Prognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes
Journal of Inflammation Research · 2026-09 · Volume 19 · 1-14
DOI: 10.2147/jir.s623570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Wenhao Xin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanyang Central Hospital, Nanyang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Even after successful primary percutaneous coronary intervention (PPCI), a substantial proportion of ST-elevation myocardial infarction (STEMI) patients develop major adverse cardiovascular events (MACE). Neutrophil extracellular trap formation (NETosis) contributes to atherothrombosis and coronary microvascular injury, but the prognostic value of circulating NETosis biomarkers in STEMI has not been systematically compared.
Methods
We studied 420 STEMI patients who survived index hospitalisation after PPCI. Plasma citrullinated histone H3 (H3Cit), cell-free DNA (cfDNA) and nucleosomes were measured at admission. The primary endpoint was MACE; all-cause death was secondary. Incremental prognostic value over a conventional model was assessed by ΔC-index, net reclassification improvement (NRI) and integrated discrimination improvement (IDI).
Results
Over a median 545-day follow-up, 81 patients (19.3%) experienced MACE and 36 (8.6%) died. In fully adjusted Cox models, each 100ng/mL increase in H3Cit was independently associated with MACE (HR 1.511, 95% CI 1.155-1.977, P=0.003) and death (HR 1.752, 95% CI 1.203-2.552, P=0.003). Q4 vs Q1-Q3 H3Cit independently predicted MACE (HR 2.139, P=0.002) and death (HR 2.836, P=0.004). cfDNA was associated with death but not MACE after adjustment; nucleosomes lost significance after full adjustment. Adding H3Cit improved discrimination for MACE (ΔC-index 0.042; NRI 0.417; IDI 0.022) and death (ΔC-index 0.055). The prognostic association of H3Cit was directionally consistent across prespecified subgroups.
Conclusion
Among three circulating NET biomarkers, H3Cit provides the strongest and most consistent prognostic information for MACE and death after STEMI and offers meaningful incremental value beyond established clinical risk factors, supporting NETosis as a potentially actionable pathway for post-STEMI risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Nanyang Central Hospital, Nanyang, People's Republic of China.
- Department of Cardiology, The Seventh People's Hospital of Zhengzhou, Zhengzhou Cardiovascular Hospital, Zhengzhou, People's Republic of China.
- Department of Cardiac Electrophysiology, The First Affiliated Hospital of Henan Medical University, Weihui, People's Republic of China.
- Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
- Henan Key Laboratory of Coronary Heart Disease Control & Prevention, Fuwai Central China Cardiovascular Hospital, Zhengzhou, People's Republic of China.
ORCID-Profile: Yipin Zhao
Zitieren
APA
Xin, W., Wang, H., Feng, Q., Wang, S., & Zhao, Y. (2026). Prognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes. Journal of Inflammation Research, Volume 19, 1-14. https://doi.org/10.2147/jir.s623570
Vancouver
Xin W, Wang H, Feng Q, Wang S, Zhao Y. Prognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes. Journal of Inflammation Research. 2026;Volume 19:1-14. doi:10.2147/jir.s623570
BibTeX
@article{Xin2026,
author = {Xin, Wenhao and Wang, Hao and Feng, Qianqian and Wang, Shengfang and Zhao, Yipin},
title = {Prognostic Value of Circulating NETosis Biomarkers in ST-Elevation Myocardial Infarction: Citrullinated Histone H3 Outperforms Cell-Free DNA and Nucleosomes},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jir.s623570}
}
EUVIMED